Tag: Survival rates
Pfizer Braftovi: Colorectal Cancer Survival Extended
Pfizer's Braftovi: Extending Survival in Colorectal CancerPfizer has recently announced a groundbreaking development in the world of oncology with their targeted cancer drug, Braftovi, showing a significant improvement in survival rates for patients with...
New Hope for Endometrial Cancer Patients with FDA-Approved Immunotherapy
The U.S. Food and Drug Administration (FDA) recently approved a new drug for certain adult patients with endometrial cancer. The drug, called Jemperli (dostarlimab-gxly), is an immunotherapy-based drug made by British pharmaceutical company GSK....
BREAKING NEWS
CDC Continues Publishing Papers Despite Firing Scientists: Flagship Journal Controversy
North Carolina Kids Find Lead in Applesauce: A Closer LookIn Hickory, North Carolina, the lead-poisoning-from-applesauce case started with two little kids showing concerning blood...
